ZEG:F AstraZeneca PLC

EUR 125.85 1.00 0.800961
Icon

AstraZeneca PLC (ZEG:F) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - General | F
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 125.85

+1.00 (+0.80)%

EUR 184.24B

1.29K

N/A

N/A

Icon

ZEG:F

AstraZeneca PLC (EUR)
COMMON STOCK | F
EUR 125.85
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 184.24B

N/A

EUR 125.85

AstraZeneca PLC (ZEG:F) Stock Forecast

N/A

Based on the AstraZeneca PLC stock forecast from 0 analysts, the average analyst target price for AstraZeneca PLC is not available over the next 12 months. AstraZeneca PLC’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of AstraZeneca PLC is Neutral, which is based on 6 positive signals and 6 negative signals. At the last closing, AstraZeneca PLC’s stock price was EUR 125.85. AstraZeneca PLC’s stock price has changed by +3.07% over the past week, +5.36% over the past month and -0.44% over the last year.

No recent analyst target price found for AstraZeneca PLC
No recent average analyst rating found for AstraZeneca PLC

Company Overview AstraZeneca PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga...Read More

https://www.astrazeneca.com

1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA

89,900

December

EUR

Germany

Adjusted Closing Price for AstraZeneca PLC (ZEG:F)

Loading...

Unadjusted Closing Price for AstraZeneca PLC (ZEG:F)

Loading...

Share Trading Volume for AstraZeneca PLC Shares

Loading...

Compare Performance of AstraZeneca PLC Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ZEG:F

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To AstraZeneca PLC (Sector: Drug Manufacturers - General )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LLY:F
Eli Lilly and Company +7.00 (+0.98%) EUR710.53B 134.17 82.69

ETFs Containing ZEG

Symbol Name ZEG's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About AstraZeneca PLC (ZEG:F) Stock

Stock Target Advisor's fundamental analysis for AstraZeneca PLC's stock is Neutral.

ZEG:F stock's dividend yield is 2.25%. Our analysis grades ZEG:F stock's dividend yield at F. This means that ZEG:F stock's dividend yield is above 22% of the stocks in the Drug Manufacturers - General sector in the F exchange. Based on this ZEG:F may be a poor dividend stock for its sector.

Unfortunately we do not have enough data on ZEG:F's stock to indicate what its average analyst target is.

ZEG:F stock's Price/Earning ratio is 33.76. Our analysis grades ZEG:F stock's Price / Earning ratio at F. This means that ZEG:F stock's Price/Earning ratio is above 70% of the stocks in the Drug Manufacturers - General sector in the F exchange. Based on this ZEG:F may be a overvalued for its sector.

The last closing price of ZEG:F's stock was EUR 125.85.

The most recent market capitalization for ZEG:F is EUR 184.24B.

Unfortunately we do not have enough analyst data on ZEG:F's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains AstraZeneca PLC's stock.

As per our most recent records AstraZeneca PLC has 89,900 Employees.

AstraZeneca PLC's registered address is 1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA. You can get more information about it from AstraZeneca PLC's website at https://www.astrazeneca.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...